aluates Reports

$ 0.0

Automative

Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-29E2895

Global Oral Solid Dosage Pharmaceutical Formulation Market Insights and Forecast to 2028

BUY CHAPTERS

Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2025

Code: QYRE-Auto-29E2895

Report

September 2025

Pages:80

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

Gilead

Merck

Novartis

Pfizer Inc

AbbVie

Boehringer Ingelheim

Oral Solid Dosage Pharmaceutical Formulation Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oral Solid Dosage Pharmaceutical Formulation Market

The global market for Oral Solid Dosage Pharmaceutical Formulation was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Oral solid dosage forms are the most commonly used pharmaceuticals to treat various disease conditions. Oral solid dosage forms are cost-effective and easy to manufacture in comparison with other dosage forms. They offer significant benefits to manufacturers such as trouble free packaging and transportation and increased chemical and physical stability. Oral solids offer many advantages to patients as well.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Pharmaceutical Formulation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Pharmaceutical Formulation.

The Oral Solid Dosage Pharmaceutical Formulation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Solid Dosage Pharmaceutical Formulation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Solid Dosage Pharmaceutical Formulation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oral Solid Dosage Pharmaceutical Formulation Market Report

Report Metric	Details
Report Name	Oral Solid Dosage Pharmaceutical Formulation Market
CAGR	5%
Segment by Type	Immediate Release Extended Release Others
Segment by Application	Hospital Pharmacy Retail Pharmacy Drug Stores Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Gilead, Merck, Novartis, Pfizer, AbbVie, Boehringer Ingelheim
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Pharmaceutical Formulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oral Solid Dosage Pharmaceutical Formulation Market report?

Ans: The main players in the Oral Solid Dosage Pharmaceutical Formulation Market are AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Gilead, Merck, Novartis, Pfizer, AbbVie, Boehringer Ingelheim

What are the Application segmentation covered in the Oral Solid Dosage Pharmaceutical Formulation Market report?

Ans: The Applications covered in the Oral Solid Dosage Pharmaceutical Formulation Market report are Hospital Pharmacy, Retail Pharmacy, Drug Stores, Others

What are the Type segmentation covered in the Oral Solid Dosage Pharmaceutical Formulation Market report?

Ans: The Types covered in the Oral Solid Dosage Pharmaceutical Formulation Market report are Immediate Release, Extended Release, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immediate Release

1.2.3 Extended Release

1.2.4 Others

1.3 Market by Application

1.3.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Drug Stores

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Perspective (2020-2031)

2.2 Global Oral Solid Dosage Pharmaceutical Formulation Growth Trends by Region

2.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Region (2020-2025)

2.2.3 Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Region (2026-2031)

2.3 Oral Solid Dosage Pharmaceutical Formulation Market Dynamics

2.3.1 Oral Solid Dosage Pharmaceutical Formulation Industry Trends

2.3.2 Oral Solid Dosage Pharmaceutical Formulation Market Drivers

2.3.3 Oral Solid Dosage Pharmaceutical Formulation Market Challenges

2.3.4 Oral Solid Dosage Pharmaceutical Formulation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue

3.1.1 Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Revenue (2020-2025)

3.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Players (2020-2025)

3.2 Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oral Solid Dosage Pharmaceutical Formulation Revenue

3.4 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio

3.4.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2024

3.5 Global Key Players of Oral Solid Dosage Pharmaceutical Formulation Head office and Area Served

3.6 Global Key Players of Oral Solid Dosage Pharmaceutical Formulation, Product and Application

3.7 Global Key Players of Oral Solid Dosage Pharmaceutical Formulation, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Type

4.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Type (2020-2025)

4.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2026-2031)

5 Oral Solid Dosage Pharmaceutical Formulation Breakdown Data by Application

5.1 Global Oral Solid Dosage Pharmaceutical Formulation Historic Market Size by Application (2020-2025)

5.2 Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031)

6.2 North America Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025)

6.4 North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031)

7.2 Europe Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025)

7.4 Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031)

8.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2020-2025)

8.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031)

9.2 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025)

9.4 Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size (2020-2031)

10.2 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025)

10.4 Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca

11.1.1 AstraZeneca Company Details

11.1.2 AstraZeneca Business Overview

11.1.3 AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Introduction

11.1.4 AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.1.5 AstraZeneca Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Details

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Introduction

11.2.4 Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Details

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Introduction

11.3.4 Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.3.5 Eli Lilly Recent Development

11.4 Gilead

11.4.1 Gilead Company Details

11.4.2 Gilead Business Overview

11.4.3 Gilead Oral Solid Dosage Pharmaceutical Formulation Introduction

11.4.4 Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.4.5 Gilead Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Oral Solid Dosage Pharmaceutical Formulation Introduction

11.5.4 Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Oral Solid Dosage Pharmaceutical Formulation Introduction

11.6.4 Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.6.5 Novartis Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Oral Solid Dosage Pharmaceutical Formulation Introduction

11.7.4 Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 AbbVie

11.8.1 AbbVie Company Details

11.8.2 AbbVie Business Overview

11.8.3 AbbVie Oral Solid Dosage Pharmaceutical Formulation Introduction

11.8.4 AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.8.5 AbbVie Recent Development

11.9 Boehringer Ingelheim

11.9.1 Boehringer Ingelheim Company Details

11.9.2 Boehringer Ingelheim Business Overview

11.9.3 Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Introduction

11.9.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

11.9.5 Boehringer Ingelheim Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Bristol–Myers Squibb

Eli Lilly

Gilead

Merck

Novartis

Pfizer Inc

AbbVie

Boehringer Ingelheim

List of Tables

Table 1. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immediate Release

Table 3. Key Players of Extended Release

Table 4. Key Players of Others

Table 5. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2020-2025)

Table 9. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2026-2031)

Table 11. Oral Solid Dosage Pharmaceutical Formulation Market Trends

Table 12. Oral Solid Dosage Pharmaceutical Formulation Market Drivers

Table 13. Oral Solid Dosage Pharmaceutical Formulation Market Challenges

Table 14. Oral Solid Dosage Pharmaceutical Formulation Market Restraints

Table 15. Global Oral Solid Dosage Pharmaceutical Formulation Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players (2020-2025)

Table 17. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2024)

Table 18. Ranking of Global Top Oral Solid Dosage Pharmaceutical Formulation Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Oral Solid Dosage Pharmaceutical Formulation, Headquarters and Area Served

Table 21. Global Key Players of Oral Solid Dosage Pharmaceutical Formulation, Product and Application

Table 22. Global Key Players of Oral Solid Dosage Pharmaceutical Formulation, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2020-2025)

Table 26. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Type (2026-2031)

Table 28. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2020-2025)

Table 30. Global Oral Solid Dosage Pharmaceutical Formulation Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Application (2026-2031)

Table 32. North America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size by Country (2026-2031) & (US$ Million)

Table 47. AstraZeneca Company Details

Table 48. AstraZeneca Business Overview

Table 49. AstraZeneca Oral Solid Dosage Pharmaceutical Formulation Product

Table 50. AstraZeneca Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 51. AstraZeneca Recent Development

Table 52. Bristol-Myers Squibb Company Details

Table 53. Bristol-Myers Squibb Business Overview

Table 54. Bristol-Myers Squibb Oral Solid Dosage Pharmaceutical Formulation Product

Table 55. Bristol-Myers Squibb Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 56. Bristol-Myers Squibb Recent Development

Table 57. Eli Lilly Company Details

Table 58. Eli Lilly Business Overview

Table 59. Eli Lilly Oral Solid Dosage Pharmaceutical Formulation Product

Table 60. Eli Lilly Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 61. Eli Lilly Recent Development

Table 62. Gilead Company Details

Table 63. Gilead Business Overview

Table 64. Gilead Oral Solid Dosage Pharmaceutical Formulation Product

Table 65. Gilead Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 66. Gilead Recent Development

Table 67. Merck Company Details

Table 68. Merck Business Overview

Table 69. Merck Oral Solid Dosage Pharmaceutical Formulation Product

Table 70. Merck Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 71. Merck Recent Development

Table 72. Novartis Company Details

Table 73. Novartis Business Overview

Table 74. Novartis Oral Solid Dosage Pharmaceutical Formulation Product

Table 75. Novartis Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 76. Novartis Recent Development

Table 77. Pfizer Company Details

Table 78. Pfizer Business Overview

Table 79. Pfizer Oral Solid Dosage Pharmaceutical Formulation Product

Table 80. Pfizer Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 81. Pfizer Recent Development

Table 82. AbbVie Company Details

Table 83. AbbVie Business Overview

Table 84. AbbVie Oral Solid Dosage Pharmaceutical Formulation Product

Table 85. AbbVie Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 86. AbbVie Recent Development

Table 87. Boehringer Ingelheim Company Details

Table 88. Boehringer Ingelheim Business Overview

Table 89. Boehringer Ingelheim Oral Solid Dosage Pharmaceutical Formulation Product

Table 90. Boehringer Ingelheim Revenue in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025) & (US$ Million)

Table 91. Boehringer Ingelheim Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Oral Solid Dosage Pharmaceutical Formulation Picture

Figure 2. Global Oral Solid Dosage Pharmaceutical Formulation Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Type: 2024 VS 2031

Figure 4. Immediate Release Features

Figure 5. Extended Release Features

Figure 6. Others Features

Figure 7. Global Oral Solid Dosage Pharmaceutical Formulation Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Application: 2024 VS 2031

Figure 9. Hospital Pharmacy Case Studies

Figure 10. Retail Pharmacy Case Studies

Figure 11. Drug Stores Case Studies

Figure 12. Others Case Studies

Figure 13. Oral Solid Dosage Pharmaceutical Formulation Report Years Considered

Figure 14. Global Oral Solid Dosage Pharmaceutical Formulation Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Oral Solid Dosage Pharmaceutical Formulation Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Region: 2024 VS 2031

Figure 17. Global Oral Solid Dosage Pharmaceutical Formulation Market Share by Players in 2024

Figure 18. Global Top Oral Solid Dosage Pharmaceutical Formulation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Pharmaceutical Formulation as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Oral Solid Dosage Pharmaceutical Formulation Revenue in 2024

Figure 20. North America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2020-2031)

Figure 22. United States Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2020-2031)

Figure 26. Germany Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Share by Region (2020-2031)

Figure 34. China Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2020-2031)

Figure 42. Mexico Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Oral Solid Dosage Pharmaceutical Formulation Market Share by Country (2020-2031)

Figure 46. Turkey Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Oral Solid Dosage Pharmaceutical Formulation Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 52. Gilead Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 55. Pfizer Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 56. AbbVie Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 57. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Pharmaceutical Formulation Business (2020-2025)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Oral Solid Dosage Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Solid Dosage Medicine Market Research Report 2025

Global Oral Sustained and Controlled Release Formulations Market Research Report 2025

Global Oral Controlled Release Drug Delivery Technology Market Research Report 2024

Global Semi Solid Formulations Drug Delivery Market Research Report 2025

Global Pharmaceutical Formulation Development Market Research Report 2025

Global Oral Solid Dose Market Research Report 2024

Global Solid Formulations Drug Delivery Market Research Report 2025

Global Oral Solid Dosage OSD Equipment Market Research Report 2025

Global Pharmaceutical Excipients for Oral Formulations Market Research Report 2024

Solid Preparation Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solid Dosage Form Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Solid Oral Nutraceutical Excipient Market Research Report 2024

Global Oral Dose Cup Market Research Report 2024

Global Composite Film for Oral Solid Preparations Market Research Report 2024

Global Solids Dosing Dispenser Market Research Report 2024

Oral Drug Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solid Dosage Pharmaceutical Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Solid Tumor Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions